Baidu’s AI Chip Unit Kunlunxin Prepares for Hong Kong IPO to Raise Up to $2 Billion 
China Reviews Meta’s $2 Billion AI Deal With Manus Amid Technology Control Concerns 
SK Hynix Shares Hit Record High as AI Memory Demand Fuels Semiconductor Rally 
Jollibee Plans U.S. Listing for International Business, Shares Rally 
BTIG Initiates Buy on SoftBank as AI and Robotics Strategy Gains Momentum 
FDA Limits Regulation of Wearable Devices and Wellness Software, Boosting Health Tech Industry 
Discord Confidentially Files for U.S. IPO, Signaling Major Milestone 
Nvidia Unveils Rubin Platform to Power Next Wave of AI Infrastructure 
Tesla UK Sales Slide as Competition Intensifies, While BYD Surges in Electric Vehicle Market 
Federal Appeals Court Blocks Trump-Era Hospital Drug Rebate Plan 
BlueScope Steel Shares Slip After Board Rejects A$13.2 Billion Takeover Bid 
Ford Targets Level 3 Autonomous Driving by 2028 with New EV Platform and AI Innovations 
Samsung Electronics Poised for Massive Q4 Profit Surge on Soaring Memory Chip Prices 
Dell Revives XPS Laptop Lineup With New XPS 14 and XPS 16 to Boost Premium PC Demand 
Chevron Seeks Expanded U.S. License to Boost Venezuelan Oil Exports Amid Sanctions Talks 
FCC Exempts Select Foreign-Made Drones From U.S. Import Ban Until 2026 
Hyundai Motor Shares Surge on Nvidia Partnership Speculation 
NEW YORK, March 31, 2016 -- The following statement is being issued by Levi & Korsinsky, LLP:
To: All persons or entities who purchased or otherwise acquired securities of Platform Specialty Products Corporation (“Platform”) (NYSE:PAH) between February 17, 2015 and March 14, 2016.
You are hereby notified that a securities class action lawsuit has been commenced in the USDC for the Southern District of Florida. If you purchased or otherwise acquired Platform securities between February 17, 2015 and March 14, 2016, your rights may be affected by this action. To get more information go to: http://www.zlk.com/pslra/platform-specialty-products-corporation.
On February 17, 2015, Platform completed its acquisition of Arysta LifeScience Limited. The complaint alleges that throughout the Class Period defendants issued false and misleading statements to investors and/or failed to disclose that: (1) Arysta made improper third-party payments in West Africa; (2) such payments were unlawful under the U.S. Foreign Corrupt Practices Act; and (3) as a result, Platforms’ public statements were materially false and misleading at all relevant times.
If you suffered a loss in Platform you have until June 1, 2016 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff. To obtain additional information, contact Joseph E. Levi, Esq. either via email at [email protected] or by telephone at (212) 363-7500, toll-free: (877) 363-5972, or visit http://www.zlk.com/pslra/platform-specialty-products-corporation.
Levi & Korsinsky is a national firm with offices in New York, New Jersey, California, Connecticut, and Washington D.C. The firm’s attorneys have extensive expertise and experience representing investors in securities litigation involving financial fraud, and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT: Levi & Korsinsky, LLP Eduard Korsinsky, Esq. 30 Broad Street - 24th Floor New York, NY 10004 Tel: (212) 363-7500 Toll Free: (877) 363-5972 Fax: (212) 363-7171 www.zlk.com
